Andre Musto

Andre Musto is a seasoned executive in the biopharmaceutical industry, currently serving as the Senior Vice President and Head of Global Cardiovascular Metabolism & Endocrinology Franchise at Merck Group since July 2014, where overall responsibility encompasses franchise strategy and P&L management. Prior experience at Merck includes roles such as Regional Vice President for the APAC region with sales exceeding 700 million Euros and Area Vice President for developed markets in Asia Pacific. Musto also spent over two decades at AstraZeneca in various leadership roles, including General Manager for New Zealand and Director of Specialty Care Business Unit in Australia. Academic qualifications include a Bachelor of Science from the University of Sydney, an MBA from Macquarie Business School, and executive education from renowned institutions such as Harvard Medical School and Stanford University.